Table 3.
Study design
|
95% Confidence interval
|
Heterogeneity
|
||||||
|
Category
|
Studies (n)
|
Effect size
|
Lower limit
|
Upper limit
|
Q
|
P value
|
df
|
Diagnosis | CP | 3 | 1.50 | 1.25 | 1.74 | 90.36 | 0.000 | 2 |
ASD | 2 | 1.35 | 0.96 | 1.71 | 0.63 | 0.43 | 1 | |
ADHD | 2 | 1.06 | 0.75 | 1.38 | 36.52 | 0.31 | 1 | |
Developmental disability | 6 | 0.48 | 0.38 | 0.58 | 273.62 | 0.000 | 5 | |
Intellectual disability | 6 | 0.14 | -0.05 | 0.34 | 232.97 | 0.000 | 5 | |
Time | 30 min | 3 | -0.01 | -0.13 | 0.11 | 1.22 | 0.54 | 2 |
40 min | 15 | 0.88 | 0.77 | 0.99 | 527.86 | 0.000 | 14 | |
Method | Individual | 20 | 0.50 | 0.43 | 0.57 | 700.33 | 0.000 | 19 |
Group | 4 | 0.26 | 0.05 | 0.47 | 46.88 | 0.000 | 3 |
CP: Cerebral palsy; ASD: Autism spectrum disorder; ADHD: Attention-deficit/hyperactivity disorder.